Capital Advisors Ltd’s Greenwich LifeSciences GLSI Stock Holding History

Capital Advisors Ltd’s Portfolio GLSI Stock Details GLSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-1	Closed	–	–	1457
2024 Q3	$0	Sell	1 -1	-50%	-$15	﹤0.01%	1470
2024 Q2	$0	Sell	2 -1	-33%	-$15	﹤0.01%	1487
2024 Q1	$0	Buy	+3	New	+$37	﹤0.01%	1430

Other funds holding GLSI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Credit Agricole Montrouge Cedex, France $38.1B AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

STRS Ohio Columbus, Ohio $25.2B AUM 30.31% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Capital Advisors Ltd's GLSI Position: Q4 2024 in Review

Capital Advisors Ltd sold out of Greenwich LifeSciences (GLSI) in Q4 2024, closing a stake of 1 share.

Capital Advisors Ltd first reported a position in GLSI in Q1 2024 and held it in 3 quarters. The position peaked at $0 in Q3 2024. 42 funds tracked by Wall St. Rank hold GLSI as of Q4 2024.

Capital Advisors Ltd reported no remaining Greenwich LifeSciences position as of Q4 2024 after selling out during the quarter.
Capital Advisors Ltd sold 1 Greenwich LifeSciences share in Q4 2024.
Capital Advisors Ltd first reported a position in Greenwich LifeSciences in Q1 2024 and held it in 3 quarters.
Capital Advisors Ltd's Greenwich LifeSciences position peaked at $0 in Q3 2024.
42 funds tracked by Wall St. Rank held Greenwich LifeSciences as of Q4 2024.

Based on Capital Advisors Ltd's 13F filing for Q4 2024, filed 4 Feb 2025.